Type 1 Diabetes Autonomic and Vascular Function
Launched by UNIVERSITY OF TEXAS AT AUSTIN · Jan 15, 2025
Trial Information
Current as of November 10, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This is a prospective observational study that looks at how the body’s automatic control systems (like heart rate and blood pressure) and blood flow in the blood vessels work in people with Type 1 diabetes compared to healthy adults. Researchers will measure vascular function (blood flow in the arms) and autonomic function (how the body regulates blood pressure) during rest and during light handgrip exercise. The study will compare two groups: adults with Type 1 diabetes and healthy controls matched for age, sex, and weight.
If you’re eligible, you’d be in one of two groups: Type 1 diabetes or healthy control. Key eligibility includes ages 18 to 70 and a BMI below 40. About 72 people are planned to participate. Participants will have tests at the University of Texas at Austin, including blood tests (glucose, cholesterol, oxidative stress, and inflammatory markers) and noninvasive measurements of blood flow and blood pressure during controlled handgrip tasks. The study is ongoing with no results yet, and it is designed to help us understand whether Type 1 diabetes affects autonomic and vascular function in adults.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Type 1 diabetes or a Healthy control
- Exclusion Criteria:
- • BMI \> 40kg/m2
- • Cancer with current treatment
- • HIV
- • Smoker cigarettes
- • Are pregnant or breastfeeding
About University Of Texas At Austin
The University of Texas at Austin, a leading research institution, is dedicated to advancing knowledge and innovation in the field of healthcare through rigorous clinical trials. Known for its commitment to scientific excellence, the university leverages its diverse expertise and cutting-edge facilities to conduct research that addresses critical health challenges. Collaborating with a multidisciplinary team of researchers, clinicians, and students, the University of Texas at Austin aims to translate scientific discoveries into effective treatments and interventions, ultimately enhancing patient outcomes and contributing to the advancement of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Austin, Texas, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported